Opinion

Video

Epidemiology, Pathophysiology, and Symptomatology of Friedreich Ataxia

Author(s):

Sub Subramony, M.D.

A Friedreich ataxia specialist discusses how the typical clinical presentation of Friedreich's Ataxia includes early onset with symptoms such as ataxia and sensory loss, while also examining the pathophysiology and incidence rate of the condition.

Video content above is prompted by the following:

  • Describe the typical clinical presentation of FA in terms of age of onset, initial symptoms, and life expectancy?
  • Can you summarize the pathophysiology and incidence rate of Friedreich's Ataxia (FA)? 
Related Videos
1 expert in this video
1 expert in this video
Barry Byrne, MD, PhD, Powell Gene Therapy Center at the University of Florida
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
Related Content
While previous research on the DVA focused on task-specific measurements, the new study focused on total composite severity percentage among patients with DMD. | Image credit: ChiccoDodiFC - stock.adobe.com
April 18th 2025

At-Home DMD Video Assessment Found Valid, Reliable

Rose McNulty
The remote measurement tool enables Duchenne muscular dystrophy (DMD) assessments through analysis of caregiver-recorded videos.
Kavita Nair Q&A - Maks_Lab - stock.adobe.com.jpeg
March 12th 2025

Coming Together to Ensure Neurological Treatment Access: Q&A With Kavita V. Nair, PhD

Christina Mattina Kavita V. Nair, PhD
In 2025, each issue of Population Health, Equity & Outcomes will feature a profile of a health system leader transforming care in their area of expertise. This issue spotlights a conversation with Kavita V. Nair, PhD, of the University of Colorado Anschutz Medical Campus.
FDA | Image credit: Postmodern Studio
February 26th 2025

Adaptive Deep Brain Stimulation Technology Receives FDA Approval for Parkinson Disease

Giuliana Grossi
The FDA approves BrainSense Adaptive deep brain stimulation and electrode identifier technology for the treatment of Parkinson disease.
Vertebral fractures are common in glucocorticoid-associated osteoporosis and are a clinical indicator of osteoporosis in young patients. | Image credit: Hugnaka - stock.adobe.com
February 14th 2025

Adults With DMD More Than Twice as Likely to Experience Fractures

Rose McNulty
Less than half of patients had undergone bone monitoring, suggesting a need for better clinical guidance and management of osteoporosis in adult men with Duchenne muscular dystrophy (DMD).
Parkinson disease | Image credit: wladimir1804 - stock.adobe.com
February 4th 2025

FDA Approves First Subcutaneous Apomorphine Device for Parkinson Disease

Skylar Jeremias
The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo), for the treatment of adults with advanced Parkinson disease.
Stroke. | Image Credit: Chinnapong - stock.adobe.com
January 30th 2025

New Model Predicts Stroke Severity and Improves Functional Independence

Cameron Santoro
A new predictive model developed by Ochsner Health helps clinicians make real-time decisions for patients who had a stroke undergoing urgent carotid intervention, improving chances of regaining functional independence.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo